These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37984034)

  • 21. Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV.
    Miller EA; McGinnis KA; Edelman EJ; Feinberg T; Gordon KS; Kerns RD; Marshall BDL; Patterson JA; McRae M
    AIDS Behav; 2024 Dec; 28(12):3994-4004. PubMed ID: 39264485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatments in panic disorder in adults: a network meta-analysis.
    Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean.
    Horey D; Kealy M; Davey MA; Small R; Crowther CA
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD010041. PubMed ID: 23897547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics.
    Meyerson BE; Linde-Krieger LB; Carter GA; Huff AJ; Brady BR; Crosby RA; De La Rosa J; Allison A; Barakat M; Pava M; Schaefer M
    Addict Sci Clin Pract; 2024 Dec; 19(1):87. PubMed ID: 39616394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of genital talc and douche use in early adolescence or adulthood with uterine fibroids diagnoses.
    Ogunsina K; Sandler DP; Murphy JD; Harmon QE; D'Aloisio AA; Baird DD; O'Brien KM
    Am J Obstet Gynecol; 2023 Dec; 229(6):665.e1-665.e10. PubMed ID: 37598998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of Mental Health Service Use During the Transition to Adulthood Among Autistic Adolescents and Young Adults.
    Davis SA; Annis IE; Hughes PM; DeJong NA; Christian RB; Ruble LA; Thomas KC
    Autism Adulthood; 2023 Dec; 5(4):366-373. PubMed ID: 38116058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a Co-Located Bridging Recovery Initiative on Hospital Length of Stay Among Patients With Opioid Use Disorder: The BRIDGE Randomized Clinical Trial.
    Marcovitz D; Dear ML; Donald R; Edwards DA; Kast KA; Le TDV; Shah MV; Ferrell J; Gatto C; Hennessy C; Buie R; Rice TW; Sullivan W; White KD; Van Winkle G; Wolf R; Lindsell CJ;
    JAMA Netw Open; 2024 Feb; 7(2):e2356430. PubMed ID: 38411964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic-based data.
    McFall AM; Ganapathi L; Gunaratne MP; Srikrishnan AK; Vasudevan CK; Anand S; Solomon SS; Mehta SH; Lucas GM
    Addiction; 2024 Nov; ():. PubMed ID: 39604070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buprenorphine use and setting type among reproductive-aged women self-reporting nonmedical prescription opioid use.
    DeSisto CL; Terplan M; Kacha-Ochana A; Green JL; Mueller T; Cox S; Ko JY
    J Subst Use Addict Treat; 2023 Dec; 155():209083. PubMed ID: 37245854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of harm reduction receipt and infectious diseases outcomes in United States Veterans with opioid use disorder and history of injection drug use.
    Shah KP; Srivastava P; Modi V; Lier AJ
    Harm Reduct J; 2024 Nov; 21(1):211. PubMed ID: 39604953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and quality of life of people living with comorbid disorders in substance use recovery residences.
    Obekpa EO; McCurdy SA; Gallardo KR; Rodriguez SA; Cazaban CG; Brown HS; Yang JJ; Wilkerson JM
    Front Public Health; 2024; 12():1412934. PubMed ID: 39628806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicaid Accountable Care Organizations and Disparities in Pediatric Asthma Care.
    Geissler KH; Shieh MS; Ash AS; Lindenauer PK; Krishnan JA; Goff SL
    JAMA Pediatr; 2024 Nov; 178(11):1208-1215. PubMed ID: 39348109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inpatient opioid withdrawal: a qualitative study of the patient perspective.
    Babbel DM; Liu P; Chen DR; Vaughn VM; Zickmund S; Bloomquist K; Zickmund T; Howell EF; Johnson SA
    Intern Emerg Med; 2024 Aug; 19(5):1291-1298. PubMed ID: 38642310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform.
    Costello RE; Tazare J; Piehlmaier D; Herrett E; Parker EPK; Zheng B; Mansfield KE; Henderson AD; Carreira H; Bidulka P; Wong AYS; Warren-Gash C; Hayes JF; Quint JK; MacKenna B; Mehrkar A; Eggo RM; Katikireddi SV; Tomlinson L; Langan SM; Mathur R; ;
    EClinicalMedicine; 2023 Jul; 61():102077. PubMed ID: 37434746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of the COVID-19 Pandemic on Age-Based Disparities in Digital Health Technology Use: Secondary Analysis of the 2017-2022 Health Information National Trends Survey.
    Qiu Y; Huang H; Gai J; De Leo G
    J Med Internet Res; 2024 Dec; 26():e65541. PubMed ID: 39631070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Framework for opioid use disorder screening and diagnosis in carceral settings.
    Jack HE; Smith CL; Brinkley-Rubinstein L; Berk J
    Int J Drug Policy; 2024 Dec; 134():104627. PubMed ID: 39476790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Walker E; Osborn DA
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine-Naloxone for Opioid Use Disorder: Reduction in Mortality and Increased Remission.
    Paul KK; Frey CG; Troung S; Paglicawan LVQ; Cunningham KA; Preston Hill T; Bothwell LG; Golovko G; Pillay Y; Jehle D
    West J Emerg Med; 2024 Nov; 25(6):869-874. PubMed ID: 39625756
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.